Bio Green Med Solution (BGMS) EBT (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly EBT of -$167000.0 for Q1 2026, up 96.03% year-over-year from -$85191.3 in Q1 2025, and up 72.44% quarter-over-quarter from -$606000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) EBT (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported EBT for 17 consecutive years, with -$167000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT rose 96.03% year-over-year to -$167000.0; the TTM figure through Mar 2026 stood at -$3.1 million (down 2466.92% YoY), while the FY2025 annual figure was -$3.0 million, down 8408.33% from the prior year.
- EBT climbed to -$167000.0 in Q1 2026 per BGMS's latest filing, from -$606000.0 in the prior quarter.
- Across five years, EBT topped out at $14.9 million in Q4 2022 and bottomed at -$7.1 million in Q1 2023.
- Historically, EBT has averaged -$2.0 million across 5 years, with a median of -$4.2 million in 2025.
- Annual changes were most pronounced in 2022 — EBT jumped 339.48% — and 2023, when it plunged 132.72%.
- Bio Green Med Solution's EBT stood at $14.9 million in 2022, then plunged by 132.72% to -$4.9 million in 2023, then soared by 308.14% to $10.2 million in 2024, then tumbled by 105.96% to -$606000.0 in 2025, then jumped by 72.44% to -$167000.0 in 2026.
- Business Quant data shows BGMS's EBT at -$167000.0 in Q1 2026, -$606000.0 in Q4 2025, and -$988000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | -767.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 312.46 Mn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | -396,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -396,000.00 |
| Mar 31, 2026 | -167,000.00 |
| Dec 31, 2025 | -606,000.00 |
| Sep 30, 2025 | -988,000.00 |
| Jun 30, 2025 | -1.25 Mn |
| Mar 31, 2025 | -4.21 Mn |
| Dec 31, 2024 | -1.89 Mn |
| Sep 30, 2024 | -2.17 Mn |
| Jun 30, 2024 | -3.67 Mn |
| Mar 31, 2024 | -4.30 Mn |
| Dec 31, 2023 | -5.69 Mn |
| Sep 30, 2023 | -6.70 Mn |
| Jun 30, 2023 | -6.03 Mn |
| Mar 31, 2023 | -7.12 Mn |
| Dec 31, 2022 | -9.00 Mn |
| Sep 30, 2022 | -6.11 Mn |
| Jun 30, 2022 | -5.56 Mn |
| Mar 31, 2022 | -5.25 Mn |
| Dec 31, 2021 | -6.24 Mn |
| Sep 30, 2021 | -5.69 Mn |